Oct. 22 at 3:53 PM
$RDHL RedHill Amends
$10 Million Equity Facility, Raising Investor Ownership Limit to 9.99%
Oct 21, 2025RedHill Biopharma amended its Any Market Purchase Agreement with Alumni Capital LP, substantially altering the structural limitations placed on the investor for specific equity drawdowns. The amendment, finalized on October 21, 2025, specifically modifies the beneficial ownership limits governing 'Forward Purchase Notices' used by RedHill to access capital.
The original Purchase Agreement, established on June 20, 2025, permits RedHill to sell up to
$10 million worth of American Depositary Shares (ADSs) to Alumni Capital. This facility provides flexible access to capital, granting RedHill the right, but not the obligation, to direct purchases.
Under a Forward Purchase Notice, RedHill may direct Alumni Capital to buy ADSs equivalent to the lesser of
$500,000 or 30% of the daily trading volume. Critically, these purchases are priced at 96% of the lowest traded price of the ADSs
